Abstract
Zihao Lai, Shuxin Fan, Haojie Zhu, Xiaohan Fan
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Hypertrophic Cardiomyopathy
10.1056/nejmra2413445 · 2025
2023 ESC Guidelines for the management of cardiomyopathies
10.1093/eurheartj/ehad194 · 2023
New perspectives on the prevalence of hypertrophic cardiomyopathy
10.1016/j.jacc.2015.01.019 · 2015
Evolving Epidemiology of Hypertrophic Cardiomyopathy: Shifting the Focus From Instant to Lifetime Risk Awareness
10.1161/circheartfailure.122.009873 · 2022
2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death
10.1093/eurheartj/ehac262 · 2022
A novel clinical risk prediction model for sudden cardiac death in hypertrophic cardiomyopathy (HCM risk-SCD)
10.1093/eurheartj/eht439 · 2014
Assessment of late gadolinium enhancement in hypertrophic cardiomyopathy improves risk stratification based on current guidelines
10.1093/eurheartj/ehad581 · 2023
2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines
10.1161/cir.0000000000001250 · 2024
Cardiac Magnetic Resonance Imaging in Asia: 2025 Status Update
10.3348/kjr.2025.1214 · 2025
Regional variability of cardiovascular magnetic resonance access and utilization in the United States
10.1016/j.jocmr.2024.101061 · 2024
Improving cardiovascular magnetic resonance access in low- and middle-income countries for cardiomyopathy assessment: rapid cardiovascular magnetic resonance
10.1093/eurheartj/ehac035 · 2022
N-terminal pro-brain natriuretic peptide and sudden cardiac death in hypertrophic cardiomyopathy
10.1136/heartjnl-2020-317701 · 2021
High-sensitivity cardiac troponin I for enhanced risk stratification in primary prevention for sudden cardiac death in hypertrophic cardiomyopathy
10.1016/j.hrthm.2026.05.010 · 2026
The autonomic nervous system and ventricular arrhythmias in myocardial infarction and heart failure
10.1111/pace.13856 · 2020
Autonomic modulation and cardiac arrhythmias: old insights and novel strategies
10.1093/europace/euab118 · 2021
Disruption of cardiac cholinergic neurons enhances susceptibility to ventricular arrhythmias
10.1038/ncomms14155 · 2017
Parasympathetic dysfunction and antiarrhythmic effect of vagal nerve stimulation following myocardial infarction
10.1172/jci.insight.86715 · 2017
Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology
1996
Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study
10.1016/s0140-6736(06)68735-7 · 2006
Multi-scale heart rate dynamics detected by phase-rectified signal averaging predicts mortality after acute myocardial infarction
10.1093/europace/eus409 · 2013
Evaluating deceleration and acceleration capacities: Implications for predicting adverse outcomes in patients with hypertrophic cardiomyopathy
2025
Neuromodulation for the Treatment of Heart Rhythm Disorders
10.1016/j.jacbts.2019.02.009 · 2019
Reduced N-Type Ca(2+) Channels in Atrioventricular Ganglion Neurons Are Involved in Ventricular Arrhythmogenesis
10.1161/jaha.117.007457 · 2018
Vagus Nerve Stimulation in Early Stage of Acute Myocardial Infarction Prevent Ventricular Arrhythmias and Cardiac Remodeling
2021
Chronic Intermittent Low-Level Stimulation of Tragus Reduces Cardiac Autonomic Remodeling and Ventricular Arrhythmia Inducibility in a Post-Infarction Canine Model
10.1016/j.jacep.2015.11.006 · 2016
The role of low-level vagus nerve stimulation in cardiac therapy
10.1080/17434440.2019.1643234 · 2019
Deceleration Capacity of Heart Rate Predicts Arrhythmic and Total Mortality in Heart Failure Patients
10.1111/anec.12343 · 2016
Deceleration capacity: A novel predictor for total mortality in patients with non-ischemic dilated cardiomyopathy
10.1016/j.ijcard.2016.06.205 · 2016
Prediction of Appropriate Shocks Using 24-Hour Holter Variables and T-Wave Alternans After First Implantable Cardioverter-Defibrillator Implantation in Patients With Ischemic or Nonischemic Cardiomyopathy
10.1016/j.amjcard.2016.04.016 · 2016
Assessment of heart rate variability in hypertrophic cardiomyopathy. Association with clinical and prognostic features
10.1161/01.cir.88.4.1682 · 1993
No additional external references are available.